* Cellebrite DI Ltd CLBT.OQ reported quarterly adjusted
earnings
of 11 cents per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of 8 cents. The mean expectation of six analysts
for the quarter was for earnings of 6 cents per share. Wall
Street expected results to range from 5 cents to 7 cents per
share.
* Revenue rose 25.7% to $93.01 million from a year ago;
analysts
expected $85.54 million.
* Cellebrite DI Ltd's reported EPS for the quarter was a
loss of 8
cents.
* The company reported a quarterly loss of $14.65 million.
* Cellebrite DI Ltd shares had risen by 11.8% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Cellebrite
DI Ltd
is $10.00
This summary was machine generated from LSEG data February 15 at
02:32 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.06 0.11 Beat
Sep. 30 2023 0.05 0.10 Beat
Jun. 30 2023 0.02 0.05 Beat
Mar. 31 2023 0.02 0.04 Beat